1. Home
  2. SCLX vs DAIO Comparison

SCLX vs DAIO Comparison

Compare SCLX & DAIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Scilex Holding Company

SCLX

Scilex Holding Company

N/A

Current Price

$2.06

Market Cap

27.9M

Sector

Health Care

ML Signal

N/A

Logo Data I/O Corporation

DAIO

Data I/O Corporation

N/A

Current Price

$2.49

Market Cap

28.2M

Sector

Industrials

ML Signal

N/A

Company Overview

Basic Information
Metric
SCLX
DAIO
Founded
2011
1969
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Electrical Products
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
27.9M
28.2M
IPO Year
2020
2026

Fundamental Metrics

Financial Performance
Metric
SCLX
DAIO
Price
$2.06
$2.49
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
★ 40.4K
29.1K
Earning Date
11-13-2026
11-10-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
N/A
★ N/A
Revenue
★ $30,253,000.00
$21,500,000.00
Revenue This Year
$118.16
$3.26
Revenue Next Year
$186.31
$25.00
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$2.27
$2.16
52 Week High
$27.00
$4.49

Technical Indicators

Market Signals
Indicator
SCLX
DAIO
Relative Strength Index (RSI) 14.46 39.11
Support Level N/A $2.24
Resistance Level $7.77 $2.76
Average True Range (ATR) 0.23 0.15
MACD -0.01 -0.02
Stochastic Oscillator 2.53 25.38

Price Performance

Historical Comparison
SCLX
DAIO

About SCLX Scilex Holding Company

Scilex Holding Co is focused on acquiring, developing and commercializing non-opioid pain management products for the treatment of acute and chronic pain. It targets indications with high unmet needs and large market opportunities with non-opioid therapies for the treatment of patients with acute and chronic pain and are dedicated to advancing and improving patient outcomes. Its commercial products are: ZTlidoO for the relief of neuropathic pain associated with postherpetic neuralgia (PHN), which is a form of post-shingles nerve pain; ELYXYB, a potential first-line treatment ready-to-use oral solution for the acute treatment of migraine in adults and GLOPERBA, the liquid oral version of the anti-gout medicine colchicine indicated for the prophylaxis of painful gout flares in adults.

About DAIO Data I/O Corporation

Data I/O Corp provides semiconductor programming, security provisioning, and intellectual property protection and management solutions used in electronics manufacturing with flash memory, microcontrollers, and flash memory-based intelligent devices as well as secure element devices, authentication devices and secure microcontrollers. It operates as a single segment entity, with the sole objective to design, manufacture, and sell programming solutions and Programming-as-a-Service (PaaS) to the world's various electronics manufacturers including OEMs, CMs and EMS companies. The company operate in three separate locations Redmond, Washington; Shanghai, China; and Munich, Germany.

Share on Social Networks: